In this regard, there is some evidence to suggest that the frequency of follow-up investigations can be based on tumor features, such as tumor differentiation, Ki-67 index, presence of metastases, and tumor size, even if no formal consensus has been reached in this regard [23,25]. The gene discussed is MKI67; the disease is neoplasm.